SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-052866
Filing Date
2012-02-10
Accepted
2012-02-10 17:03:59
Documents
6
Period of Report
2012-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d298940d8k.htm 8-K 22005
2 UNDERWRITING AGREEMENT d298940dex11.htm EX-1.1 136247
3 OPINION AND CONSENT OF DLA PIPER LLP (US) d298940dex51.htm EX-5.1 7054
4 HALOZYME ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK d298940dex991.htm EX-99.1 8049
5 HALOZYME ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK d298940dex992.htm EX-99.2 6530
6 GRAPHIC g298940g13w41.jpg GRAPHIC 7834
  Complete submission text file 0001193125-12-052866.txt   192098
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 12593879
SIC: 2836 Biological Products, (No Diagnostic Substances)